Trans-10, cis-12 conjugated linoleic acid (t10,c12 CLA) and trans-10 18:1 (t10-18:1) are the main ruminal biohydrogenation intermediates of linoleic acid (LNA) produced under high-grain feedlot diets. T10,c12 CLA has anti-lipogenic effects, including reducing Δ9-desaturase activity in adipocytes and consequently decreasing lipid synthesis and oleic acid concentration in beef fat. However, the bioactivity of t10-18:1 remains poorly studied despite its much higher concentration in serum and adipose tissues of feedlot cattle. This study aims to elucidate the impact of LNA and its t-10 biohydrogenation intermediates (t10,c12 CLA and t-10 18:1) on lipid metabolism and fatty acid composition in intramuscular bovine adipocytes. Primary intramuscular adipocytes were isolated from three feedlot-finished Angus steers and were then cultured and differentiated followed by treatment with c-10 18:1 (control), t-10 18:1, t10,c12 CLA or linoleic acid (LNA) at 25, 50 or 100uM in maturation media for 9 days before harvest. Gene expression via qPCR and gas chromatography-FID demonstrate t10-18:1, but not c10-18:1, increased (p < 0.05) SCD-1 mRNA expression and the c9 18:1/18:0 desaturation index in a concentration-dependent manner. T10,c12 CLA and LNA decreased (p < 0.05) expression of lipogenic genes, including FAS and ACC1, while CPT1 expression was increased (p < 0.05) with both treatments. Overall, t10,c12 CLA and t10-18:1 had distinct effects on lipogenesis, whereas LNA and t10,c12 CLA showed similar effects on bovine adipocytes.
No takes yet. Share an insight, caveat, or question.
Tsonov et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: